These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2709349)

  • 41. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.
    Woods SW; Morgenstern H; Saksa JR; Walsh BC; Sullivan MC; Money R; Hawkins KA; Gueorguieva RV; Glazer WM
    J Clin Psychiatry; 2010 Apr; 71(4):463-74. PubMed ID: 20156410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The dyskinesia identification system--Coldwater (DIS-Co): a tardive dyskinesia rating scale for the developmentally disabled.
    Sprague RL; Kalachnik JE; Breuning SE; Davis VJ; Ullmann RK; Cullari S; Davidson NA; Ferguson DG; Hoffner BA
    Psychopharmacol Bull; 1984; 20(2):328-38. PubMed ID: 6728999
    [No Abstract]   [Full Text] [Related]  

  • 43. Changing epidemiology of tardive dyskinesia: an overview.
    Jeste DV; Wyatt RJ
    Am J Psychiatry; 1981 Mar; 138(3):297-309. PubMed ID: 6110344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tremor and tardive dyskinesia.
    Hansen TE; Glazer WM; Moore DC
    J Clin Psychiatry; 1986 Sep; 47(9):461-4. PubMed ID: 2875065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
    Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N
    J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electroencephalogram in tardive dyskinesia.
    Wolf ME; Koller WC; Mosnaim AD
    Clin Electroencephalogr; 1984 Oct; 15(4):222-5. PubMed ID: 6151428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of tardive dyskinesia in psychiatric outpatients using a standardized rating scale.
    Rey JM; Hunt GE; Johnson GF
    Aust N Z J Psychiatry; 1981 Mar; 15(1):33-7. PubMed ID: 6973337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of tardive dyskinesia.
    Tepper SJ; Haas JF
    J Clin Psychiatry; 1979 Dec; 40(12):508-16. PubMed ID: 40964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospective study of tardive dyskinesia in the elderly: rates and risk factors.
    Woerner MG; Alvir JM; Saltz BL; Lieberman JA; Kane JM
    Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study.
    Ganzini L; Heintz RT; Hoffman WF; Casey DE
    Arch Gen Psychiatry; 1991 Mar; 48(3):259-63. PubMed ID: 1671743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical forms of severe tardive dyskinesia.
    Gardos G; Cole JO; Salomon M; Schniebolk S
    Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.
    Arango C; Adami H; Sherr JD; Thaker GK; Carpenter WT
    Am J Psychiatry; 1999 Jul; 156(7):1097-9. PubMed ID: 10401460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Tardive dyskinesia with special emphasis on tardive dyskinesia caused by neuroleptics].
    Preradović M; Ilić T; Bjelica N
    Vojnosanit Pregl; 1996; 53(6):519-26. PubMed ID: 9229972
    [No Abstract]   [Full Text] [Related]  

  • 55. Prevention and management of tardive dyskinesia.
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia.
    Stahl SM; Yesavage JA; Berger PA
    J Clin Psychiatry; 1982 Nov; 43(11):445-6. PubMed ID: 7174619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Torticollis spasmodicus as a manifestation of tardive dystonia].
    Silberbauer C; Rittmannsberger H
    Fortschr Neurol Psychiatr; 1995 Oct; 63(10):388-92. PubMed ID: 8529987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA; Rexroth K
    Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intermittent neuroleptic therapy and tardive dyskinesia: a literature review.
    Goldman MB; Luchins DJ
    Hosp Community Psychiatry; 1984 Dec; 35(12):1215-9. PubMed ID: 6150891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.